HB 1713
restricting the over-the-counter sale of pseudeophedrine base and ephedrine base drugs and establishing commission to study the feasibility of an electronic tracking system for sales of pseudeophedrine base and ephedrine base drugs.
Status: Laid on the table
This page draws the record — sponsors, votes, hearings, committee reports and the bill text — in the browser, so it needs JavaScript. Everything it shows comes from the files linked below, which need none.
All bills